News roundup: Baton Rouge Planning Commission OKs new apartment complex, restaurants … Louisiana lawmakers seek to name clinic after Medal of Honor winner … Blood-testing firm Theranos to dissolve

    Onward: The Baton Rouge Planning Commission on Monday gave the go-ahead for a 216-unit apartment complex near the corner of North Ardenwood Drive and Florida Boulevard. The complex will have nine residential buildings with 24 single-bedroom units, 96 two-bedroom units and another 96 three-bedroom units, according to application material. A final plan for a Chicken Salad Chick at the corner of West Lee and Burbank drives also got approval, and Cypress Coast Brewing was recommended for a commercial alcohol rezoning to build a craft brewery and taproom on Government Street near Jefferson Highway. The Metro Council must also approve the brewery’s rezoning. See the full meeting agenda and video.

    Honor: Members of Louisiana’s congressional delegation are seeking to rename a veteran’s clinic in Lake Charles after a Medal of Honor winner who died in Vietnam. U.S. Sens. Bill Cassidy and John Kennedy and Rep. Clay Higgins announced their legislation Monday in a news release. They hope to have the Lake Charles Community-Based Outpatient Clinic named after Douglas Fournet.The Kinder native was a U.S. Army lieutenant. Monday’s announcement says he is the only person from Southwest Louisiana to be awarded the Medal of Honor. The legislation would name the Lake Charles facility the “Douglas Fournet Department of Veterans Affairs Clinic.” Read the full story.

    Clotted: Theranos Inc., the blood-testing company accused of perpetrating Silicon Valley’s biggest fraud, will soon cease to exist. In the wake of a high-profile scandal, the company will formally dissolve, according to an email to shareholders, The Wall Street Journal reports. Theranos will seek to pay unsecured creditors its remaining cash in coming months, the email said. The move comes after federal prosecutors filed criminal charges against Theranos founder Elizabeth Holmes and the blood-testing company’s former No. 2 executive, alleging that they defrauded investors out of hundreds of millions of dollars and defrauded doctors and patients. The executives have denied the charges and face a coming criminal trial. Read the full story.  

    View Comments